Management of the neovascular choroidal membrane secondary to ocular toxoplasmosis.

Management of the neovascular choroidal membrane secondary to ocular toxoplasmosis.
Arch Soc Esp Oftalmol. 2019 Dec 23;:
Authors: Martín García E, Chávarri García JJ, Rodríguez Vicente L, Jiménez Del Río B, Guallar Leza SM, Del Río Mayor JL
Abstract
A 12-year-old patient diagnosed with congenital toxoplasmosis, with no systemic treatment at the time, who presented with a decreased visual acuity (VA) in his left eye (LE). On examination, VA in the LE was 0.05 and the fundus examination revealed a focus of chorioretinitis adjacent to a pigmented macular scar, as well as a large associated subretinal haemorrhage. After confirming the diagnosis of choroidal neovascular membrane secondary to ocular toxoplasmosis, treatment was started with systemic anti-toxoplasmosis drugs and two anti-VEGF intravitreal injections separated by one month. Finally, the patients had a VA in LE of 0.4, with reabsorption of the haemorrhage, leaving an inactive pigmented macular scar. The use of anti-VEGF intravitreal injections in cases of ocular toxoplasmosis has been associated with a reactivation of old lesions, so the prophylactic use of oral anti-toxoplasmosis drugs is recommended in these cases.
PMID: 31879139 [PubMed - as supplied by publisher]

Source: Archivos de la Sociedad Espanola de Oftalmologia - December 29, 2019 Category: Opthalmology Tags: Arch Soc Esp Oftalmol Source Type: research